Yoon-Seob Lee

Dr. Yoon-Seob Lee


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
YMYoung Min
Young Min
YLYoon-Seob Lee
Yoon-Seob Lee
JLJuwon Lee
Juwon Lee
DKDayoung Keum
Dayoung Keum
JGJooYoung Gwag
JooYoung Gwag
Sung-Ung KangSung-Ung Kang
Sung-Ung Kang
Dementia is a growing global health concern in aging societies, leading to a progressive decline in cognitive function that severely impairs daily life. Despite the growing burden, effective preventive and therapeutic strategies remain elusive, emphasizing the urgent need for novel interventions. Recent advances underscore the pivotal role of neuroinflammation in dementia pathogenesis, particularly in Alzheimer’s disease (AD). Chronic activation of central nervous system immune cells, particularly microglia, exacerbates neurodegeneration and establishes a self-perpetuating cycle of inflammation and cognitive decline. This review focuses on emerging research exploring the cGAS-STING pathway’s role in dementia, examining its potential as a diagnostic and therapeutic target. The cGAS-STING pathway, integral to innate immune responses, may contribute to the chronic neuroinflammation seen in neurodegenerative diseases. By targeting this pathway, new strategies could mitigate the inflammatory processes that drive neuronal loss, offering a promising avenue for therapeutic development in dementia.

6 February 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SJSung-min Jeon
Sung-min Jeon
SCStanley Cho
Stanley Cho
YLYoon-Seob Lee
Yoon-Seob Lee
JLJiyu Lee
Jiyu Lee
EKEunice J. Kang
Eunice J. Kang
Sung-Ung KangSung-Ung Kang
Sung-Ung Kang
While phosphatidylserine (PS) is recognized for its neuroprotective properties, the effects of PS purity on human cortical neurons remain unexplored. This study investigates the effects of three different PS purities (15 µM of 50%, 70%, and 80%) on neuronal health using human-embryonic-stem-cell-derived cortical neurons. Our findings reveal that higher PS purity enhances the expression of key regulatory proteins Sirtuin 1 (SIRT1) and Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), known for their roles in neuroprotection and mitochondrial function. Specifically, 80% PS purity significantly increases SIRT1 and PGC-1α levels, suggesting that PS purity strengthens neuroprotective pathways and improves mitochondrial quality control. Through SIRT1 knockdown experiments, we demonstrate that PS-induced upregulation of PGC-1α is SIRT1 dependent, highlighting a SIRT1-PGC-1α regulatory axis that enhances mitochondrial health. In an amyloid-beta 1–42 (Aβ42)-induced Alzheimer’s disease (AD) model, PS treatment reduced cytotoxicity and countered the Aβ42-induced downregulation of SIRT1 and PGC-1α, particularly at 70% and 80% PS purity, indicating PS’s role in preserving neuronal viability and combating AD-like pathology. These results suggest that the biological activity of PS preparations in vitro can depend on purity, motivating future studies to define compositional determinants and bioavailability relevant to translational applications.

15 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
YMYoung Min
Young Min
YLYoon-Seob Lee
Yoon-Seob Lee
JLJu-Won Lee
Ju-Won Lee
DKDayoung Keum
Dayoung Keum
JGJooYoung Gwag
JooYoung Gwag
Sung-Ung KangSung-Ung Kang
Sung-Ung Kang
Dementia, characterized by a progressive decline in cognitive function, is a growing global health concern due to the aging population. It affects memory, executive function, language, and other cognitive capacities, significantly impairing daily life. Despite the growing burden, effective preventive and therapeutic strategies remain elusive, emphasizing the urgent need for novel interventions. Recent advances underscore the pivotal role of neuroinflammation in dementia pathogenesis, particularly in Alzheimer's disease (AD). Chronic activation of immune cells within the central nervous system, such as microglia transition from a homeostatic to a pro-inflammatory state called Disease-associated microglia status 1 and 2 (DAM1 or DAM2), exacerbates neurodegeneration, creating a self-perpetuating cycle of inflammation and cognitive decline. This review focuses on emerging research exploring the cGAS-STING pathway’s role in dementia, examining its potential as a diagnostic and therapeutic target. The cGAS-STING pathway, integral to innate immune responses, may contribute to the chronic neuroinflammation seen in neurodegenerative diseases. By targeting this pathway, new strategies could mitigate the inflammatory processes that drive neuronal loss, offering a promising avenue for therapeutic development in dementia.

25 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SJSung-min Jeon
Sung-min Jeon
SCStanley Cho
Stanley Cho
YLYoon-Seob Lee
Yoon-Seob Lee
JLJiyu Lee
Jiyu Lee
EKEunice J. Kang
Eunice J. Kang
Sung-Ung KangSung-Ung Kang
Sung-Ung Kang
While phosphatidylserine (PS) is recognized for its neuroprotective properties, the effects of PS purity on human cortical neurons remains unexplored. This study investigates three different PS purities (15 µM of 50%, 70%, and 80%) on neuronal health using human embryonic stem cell-derived cortical neurons. Our findings reveal that higher PS purity enhances the expression of key regulatory proteins SIRT1 and PGC-1α, known for their roles in neuroprotection and mitochondrial function. Specifically, 80% purity PS significantly increases SIRT1 and PGC-1α levels, suggesting that PS purity strengthens neuroprotective pathways and improves mitochondrial quality control. Through SIRT1 knockdown experiments, we demonstrate that PS-induced upregulation of PGC-1α is SIRT1-dependent, highlighting a SIRT1-PGC-1α regulatory axis that enhances mitochondrial health. In an amyloid-beta (Aβ42)-induced Alzheimer’s disease (AD) model, PS treatment, particularly at 70% and 80% purity, reduced cytotoxicity and countered the Aβ42-induced downregulation of SIRT1 and PGC-1α, indicating PS’s role in preserving neuronal viability and combating AD-like pathology. Further analyses showed that PS purity modulates mitochondrial fission and fusion gene expression, which are often dysregulated in neurodegenerative diseases, thereby restoring mitochondrial integrity and reducing oxidative stress. These results emphasize the importance of PS purity in human cortical neuron models and suggest that PS, as a nutritional supplement or a potential treatment for early Alzheimer’s patients, could be applied effectively in neurodegeneration strategies, targeting mitochondrial dysfunction.